What to Expect on Week 2 of Mounjaro

What the trial data tell us about early weeks on tirzepatide

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed more than 2,500 adults with obesity over 72 weeks on tirzepatide. The average weight reductions at the highest dose were around 20–21%, but those results accumulated over the full course. In the early weeks, the medicine is doing quieter work: calibrating your body's response to a dual GIP and GLP-1 receptor signal, slowing gastric emptying and beginning to modulate appetite. Visible scale movement in week two is not what the evidence is tracking.

The NHS tirzepatide information page confirms that gastrointestinal side effects are the most commonly reported, particularly at the start of treatment or after a dose step-up. Week two still counts as 'the start of treatment', which matters when you are trying to interpret your own experience. Nausea, constipation, burping, loose stools or a general feeling of queasiness are all well-documented at this stage. They are unpleasant but expected, and they do settle for most people within days to two weeks.

One misconception worth letting go of gently: some people come in expecting week two to feel dramatically different from week one. In practice, the gap is usually small. The dose has not changed, the medicine's half-life means plasma levels are still climbing towards a steady state, and your digestive system is still finding its rhythm. Progress at this stage is measured in tolerance, not transformation.

The side effects most commonly reported in week two

Nausea sits at the top of the list, not for everyone, and rarely severe, but often present after meals or when the pen is due. Eating smaller portions, choosing lower-fat foods and staying upright after eating all help. Constipation affects a meaningful proportion of people early on because tirzepatide slows gut transit; keeping hydrated and including fibre-rich foods is genuinely useful here, not just stock advice.

Fatigue is another week-two companion for some. The body is processing a new hormonal signal, appetite is shifting and, if nausea has disrupted eating, energy intake may be lower than usual. A brief dip in energy is not a sign something is wrong. Headaches, dizziness and indigestion are also reported in the early weeks and align with what the prescribing information describes.

Injection-site reactions (mild redness, itching or a small firm spot) are common and temporary. Rotating between the abdomen, thigh and upper arm, and letting the pen reach room temperature before injecting, both reduce discomfort. For practical guidance on technique and what normal reactions look like, our tirzepatide overview page covers the specifics in more detail.

A few things are worth escalating rather than waiting out: severe or persistent stomach pain that radiates to the back, signs of an allergic reaction, or any symptom that feels out of proportion. The MHRA has issued clear guidance on recognising pancreatitis (rare but serious) and you can report any concern through the Yellow Card scheme. Contact your prescriber or NHS 111 if anything worries you.

Appetite and weight: what week two realistically looks like

Most people notice some appetite change by week two, though the degree varies considerably. You may find you reach fullness sooner, forget to finish a meal, or feel less driven by habitual hunger cues between meals. Some people feel very little of this yet, and that is also within normal range.

Weight loss, if it appears at all, tends to be modest at this stage. Some of it reflects reduced calorie intake, some reflects water changes from eating less. Neither number nor absence of a number tells you whether the medicine is working in the way it should over the longer course. The fuller picture of how long Mounjaro takes to work explains why the meaningful weight-loss signal typically builds from months two and three onwards.

If you are curious about cost and what private treatment includes for the duration, the Mounjaro price comparison page sets out what transparent pricing covers in the UK private market.

For a broader view of the whole first-month experience, week one and the fuller Mounjaro expectations guide both sit alongside this page. And if something is coming up that you want to discuss directly, our aftercare team is available seven days a week.

When to speak to your prescriber rather than waiting

Week two is exactly the kind of moment people sometimes talk themselves out of raising a concern, things feel borderline, not dramatic. Our prescribers hear this regularly. The right test is not whether a symptom is severe enough to seem worth mentioning; it is whether it is affecting your ability to eat, stay hydrated or function day to day.

Persistent vomiting that stops you keeping fluids down, stomach pain that builds rather than eases, visible swelling or a rash beyond the injection site, all of these need a clinical conversation sooner rather than later. For context on the longer arc of what to expect from Mounjaro across your first months, this guide covers the treatment journey in full.

Mounjaro is a prescription-only medicine, and the clinical review that sits behind every repeat order is there precisely for moments like this. If you have not yet started treatment and want to understand whether it might be right for you, our prescribers are available to review your details the same day. Start your free consultation here.